Prosecution Insights
Last updated: October 27, 2026

Karen Amanda Hranek, USPTO Patent Examiner

Listed by the USPTO as HRANEK, KAREN AMANDA

Tech Center 3600 • Art Units: 3626 3684 3685

This examiner grants 35% of resolved cases

Analysis

HRANEK, KAREN AMANDA is a USPTO patent examiner in tech center 3600 and art unit 3626. The record contains 196 resolved cases, an allowance rate of 34.7%, and a median of 1228 days to allowance. The interview lift is 40.4%, so interview strategy is an important consideration when addressing prosecution before this examiner.

The top companies are KPN Innovations LLC, Boston Scientific Corporation, and Rom Technologies Inc. The associated firms are CALDWELL LLC, Bridgeway IP Law Group, PLLC, and Dickinson Wright PLLC - Washington DC. Practitioners can use the profile to prepare focused claim arguments and evaluate whether an interview should accompany a written response.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

34.7%
Allow Rate
-17.3% vs TC avg
237
Total Applications
+40.4%
Interview Lift
1228
Avg Prosecution Days
Based on 196 resolved cases, 2023–2026

Rejection Statute Breakdown

30.1%
§101 Eligibility
10.2%
§102 Novelty
36.3%
§103 Obviousness
21.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18466903 SYSTEMS AND METHODS FOR PLANNING MEDICAL PROCEDURES Non-Final OA Boston Scientific Scimed, Inc.
19055313 SYSTEM AND METHOD FOR AN ENHANCED HEALTHCARE PROFESSIONAL USER INTERFACE DISPLAYING MEASUREMENT INFORMATION FOR A PLURALITY OF USERS Final Rejection ROM TECHNOLOGIES, INC.
19169272 MACHINE LEARNING TO PREDICT PATIENT OUTCOMES BASED ON POSITIONING Final Rejection MatrixCare, Inc.
18578721 CLINICAL THERAPEUTIC DRUG PREDICTION AND RECOMMENDATION SYSTEM AND METHOD FOR EVALUATING EFFICACY OF SECOND-GENERATION HORMONE DRUG IN TREATMENT OF PROSTATE CANCER Non-Final OA Kaohsiung Medical University
18391460 MAPPING ELECTRONIC MESSAGES TO LABORATORY RESULT IDENTIFIERS TO INFORM PATIENT TREATMENT AND CLINICAL TRIAL DESIGN Final Rejection Flatiron Health, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Karen Amanda Hranek's allowance rate?

34.7% of resolved applications examined by Karen Amanda Hranek were allowed (196 resolved cases), compared with 24.6% across Art Unit 3626 over the last five years.

Does an interview help with examiner Karen Amanda Hranek?

This examiner's interview lift is +40.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Karen Amanda Hranek take to allow a patent?

Applications allowed by Karen Amanda Hranek took 1,228 days on average from filing to allowance.

Which art unit does examiner Karen Amanda Hranek work in?

Karen Amanda Hranek examines applications in Art Unit 3626 in Tech Center 3600 (Transportation, E-Commerce & Mechanical Systems).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month